nach oben

Journal of Community Health

Erschienen in:

01.04.2014 | Original Paper

Ethnic and Gender Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among White and Hispanic Men and Women

verfasst von: Rachel A. Reimer, Julie A. Schommer, Amy E. Houlihan, Meg Gerrard

Erschienen in: Journal of Community Health | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to examine factors associated with human papillomavirus (HPV) knowledge and awareness, and HPV vaccination among White and Hispanic males and females. Differences in HPV knowledge, sources of information, vaccine awareness, vaccination status, and interest in vaccination were examined. A community sample was recruited from local health care clinics in a medium sized Midwestern city between May 2010 and December 2011. Participants (N = 507) were White (n = 243) and Hispanic, males (n = 202) and females between the ages of 15–30. Results indicate that White and female participants were significantly more likely to have heard of HPV, have higher levels of HPV knowledge, have been diagnosed with HPV, and be aware of the HPV vaccine for women. White and female participants were also more likely to have heard of HPV from their physician and were significantly more interested in receiving the HPV vaccine in the future. There was no effect of ethnicity on interest in the vaccine per a doctor’s recommendation, however. Findings suggest that Whites and females have greater levels of HPV awareness and knowledge and that, while Hispanic participants are less likely than White participants to be told about the HPV vaccine from their provider, they may be equally receptive to such a recommendation.

Allen, J. D., Othus, M. K., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(9), 2187–2198. doi:10.1158/1055-9965.EPI-10-0217.CrossRef

Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., et al. (2010). SEER cancer statistics review, 1975–2007. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/.

Baer, H., Allen, S., & Braun, L. (2000). Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research. Journal of Community Health, 25(1), 67–78.PubMedCrossRef

Barnholtz-Sloan, J., Patel, N., Rollison, D., Kortepeter, K., MackKinnon, J., & Giuliano, A. R. (2009). Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes and Control, 20(7), 1129–1138. doi:10.1007/s10552-009-9317-z.PubMedCrossRef

Boehner, C. W., Howe, S. R., Bernstein, D. I., & Rosenthal, S. L. (2003). Viral sexually transmitted disease vaccine acceptability among college students. Sexually Transmitted Diseases, 30(10), 774–778. doi:10.1097/01.OLQ.0000078823.05041.9E.PubMedCrossRef

Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45(2–3), 107–114. doi:10.1016/j.ypmed.2007.05.013.PubMedCrossRef

Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20), 630–632.

Centers for Disease Control and Prevention. (2012). Human papillomavirus-associated cancers-United States, 2004–2008. Morbidity and Mortality Weekly Report, 61(15), 258–261.

Centers for Disease Control and Prevention. (2012). National and state vaccination coverage among adolescents aged 13–17 years—United States 2011. Morbidity and Mortality Weekly Report, 61(34), 258–261.

10.

Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP). Morbidity Mortality Weekly Report, 60(50), 1705–1708.

11.

Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., et al. (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29(32), 4294–4301. doi:10.1200/JCO.2011.36.4596.CrossRef

12.

Colon-Lopez, V., Ortiz, A. P., Toro-Mejias, L. M., Garcia, H., Clatts, M. C., & Palefsky, J. (2012). Awareness and knowledge of human papillomavirus (HPV) infection among high-risk men of Hispanic origin attending a sexually transmitted infection (STI) clinic. BMC Infectious Diseases, 12, 346. doi:10.1186/1471-2334-12-346.PubMedCentralPubMedCrossRef

13.

Daley, M. F., Liddon, N., Crane, L. A., Beaty, B. L., Barrow, J., Babbel, C., et al. (2006). A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118(6), 2280–2289. doi:10.1542/peds.2006-1946.PubMedCrossRef

14.

Davis, K., Dickman, E. D., Ferris, D., & Dias, J. K. (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 8(3), 188–194.PubMedCrossRef

15.

Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117(5), 1486–1493. doi:10.1542/peds.2005-1381.PubMedCrossRef

16.

Downs, L. S., Smith, J. S., Scarinci, I., Flowers, L., & Parham, G. (2008). The disparity of cervical cancer in diverse populations. Gynecologic Oncology, 109(2 Suppl), S22–S30. doi:10.1016/j.ygyno.2008.01.003.PubMedCrossRef

17.

Duggan, C., Coronado, G., Martinez, J., Byrd, T. L., Carosso, E., Lopez, C., et al. (2012). Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: A randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women. BMC Cancer, 12, 170. doi:10.1186/1471-2407-12-170.PubMedCentralPubMedCrossRef

18.

Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006). Prevalence of HPV infection among men: A systematic review of the literature. The Journal of Infectious Diseases, 194(8), 1044–1057. doi:10.1086/507432.PubMedCrossRef

19.

Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., et al. (2007). Prevalence of HPV infection among females in the United States. JAMA, the Journal of the American Medical Association, 297(8), 813–819. doi:10.1001/jama.297.8.813.CrossRef

20.

Ferris, D. G., Waller, J. L., Miller, J., Patel, P., Price, G. A., Jackson, L., et al. (2009). Variables associated with human papillomavirus (HPV) vaccine acceptance by men. Journal of the American Board of Family Medicine: JABFM, 22(1), 34–42. doi:10.3122/jabfm.2009.01.080008.PubMedCrossRef

21.

Friedman, A. L., & Shepeard, H. (2007). Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 34(3), 471–485. doi:10.1177/1090198106292022.CrossRef

22.

Gerend, M. A., Lee, S. C., & Shepherd, J. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34(7), 468–471. doi:10.1097/01.olq.0000245915.38315.bd.PubMed

23.

Gerend, M. A., & Magloire, Z. F. (2008). Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 42(3), 237–242. doi:10.1016/j.jadohealth.2007.08.022.CrossRef

24.

Gerend, M. A., & Shepherd, J. E. (2011). Correlates of HPV knowledge in the era of HPV vaccination: A study of unvaccinated young adult women. Women and Health, 51(1), 25–40. doi:10.1080/03630242.2011.540744.PubMedCentralPubMedCrossRef

25.

Gilbert, P. A., Brewer, N. T., & Reiter, P. L. (2011). Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: A national study of gay men. Journal of Lower Genital Tract Disease, 15(2), 83–88. doi:10.1097/LGT.0b013e3181f1a960.PubMedCrossRef

26.

Griffioen, A. M., Glynn, S., Mullins, T. K., Zimet, G. D., Rosenthal, S. L., Fortenberry, J. D., et al. (2012). Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clinical Pediatrics, 51(6), 560–568. doi:10.1177/0009922812443732.PubMedCentralPubMedCrossRef

27.

Hoover, D. R., Carfioli, B., & Moench, E. A. (2000). Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care for Women International, 21(5), 375–391. doi:10.1080/07399330050082227.PubMedCrossRef

28.

Jaccard, J. J. (2001). Interaction effects in logistic regression. Quantitative applications in the social sciences (series 135). Newbury Park, CA: Sage.

29.

Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48(5), 426–431. doi:10.1016/j.ypmed.2008.11.010.PubMedCrossRef

30.

Janicki, D. L., Kamarck, T. W., Shiffman, S., Sutton-Tyrrell, K., & Gwaltney, C. J. (2005). Frequency of spousal interaction and 3-year progression of carotid artery intima medial thickness: The Pittsburgh healthy heart project. Psychosomatic Medicine, 67(6), 889–896. doi:10.1097/01.psy.0000188476.87869.88.PubMedCrossRef

31.

Kahn, J. A., Lan, D., & Kahn, R. S. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics and Gynecology, 110(1), 87–95. doi:10.1097/01.AOG.0000266984.23445.9c.PubMedCrossRef

32.

Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (HPV): College male’s knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men’s Health, 8(3), 175–184. doi:10.1016/j.jomh.2011.04.002.PubMedCentralPubMedCrossRef

33.

Kiecolt-Glaser, J. K., & Newton, T. L. (2001). Marriage and health: His and hers. Psychological Bulletin, 127(4), 472–503.PubMedCrossRef

34.

Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: A review of the literature. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 46(2), 113–123. doi:10.1016/j.jadohealth.2009.11.199.CrossRef

35.

Markowitz, L. E., Dunne, E., Saraiya, M., Lawson, H. J., Chesson, H., & Unger, E. (2007). Centers for Disease Control and Prevention: Quadrivalent human papillomavirus vaccine from the recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 56, 1–24.

36.

Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000). Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 151(12), 1158–1171.

37.

Nandwani, M. C. (2010). Men’s knowledge of the human papillomavirus vaccine. The Nurse Practitioner, 35(11), 32–39. doi:10.1097/01.NPR.0000388900.49604.e1.PubMedCrossRef

38.

Pagliusi, S. (2010). World Health Organization. Accessed January 23, 2013, http://www.who.int/vaccines/en/dpvrd.shtml.

39.

Reimer, R. A., Houlihan, A. E., Gerrard, M., Deer, M. M., & Lund, A. J. (2012). Ethnic differences in predictors of HPV vaccination: Comparisons of predictors for Latina and non-Latina White women. Journal of Sex Research,. doi:10.1080/00224499.2012.692406.PubMed

40.

Reiter, P. L., McRee, A. L., Gottlieb, S. L., & Brewer, N. T. (2010). HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure. Vaccine, 28(38), 6292–6297. doi:10.1016/j.vaccine.2010.06.114.PubMedCentralPubMedCrossRef

41.

Reiter, P. L., McRee, A. L., Kadis, J. A., & Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595–5602. doi:10.1016/j.vaccine.2011.06.020.PubMedCentralPubMedCrossRef

42.

Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Mariotto, A., et al. (2002). SEER cancer statistics review, 1975–2002. National Cancer Institute Bethesda, MD. http://seer.cancer.gov/csr/1975_2002/.

43.

Roberts, M. E., Gerrard, M., Reimer, R., & Gibbons, F. X. (2010). Mother–daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125(5), 982–989. doi:10.1542/peds.2009-2888.PubMedCrossRef

44.

Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. (2011). Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine, 29(5), 890–895. doi:10.1016/j.vaccine.2009.12.063.PubMedCrossRef

45.

Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., … Weinstock, H. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases, 40(3), 187–193.

46.

Stock, M. L., Peterson, L. M., Houlihan, A. E., & Walsh, L. A. (2013). Influence of oral sex and oral cancer information on young adults’ oral sexual-risk cognitions and likelihood of HPV vaccination. Journal of Sex Research, 50(1), 95–102. doi:10.1080/00224499.2011.642904.PubMedCrossRef

47.

U.S. Food and Drug Administration. (2006). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm.

48.

Watson, M., Saraiya, M., Benard, V., Coughlin, S. S., Flowers, L., Cokkinides, V., et al. (2008). Burden of cervical cancer in the United States, 1998–2003. Cancer, 113(10 Suppl), 2855–2864. doi:10.1002/cncr.23756.PubMedCrossRef

49.

Zimet, G. D., Mays, R. M., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Acceptability of human papillomavirus immunization. Journal of Women’s Health & Gender-Based Medicine, 9(1), 47–50. doi:10.1089/152460900318957.CrossRef

Titel: Ethnic and Gender Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among White and Hispanic Men and Women
verfasst von: Rachel A. Reimer
Julie A. Schommer
Amy E. Houlihan
Meg Gerrard
Publikationsdatum: 01.04.2014
Verlag: Springer US
Erschienen in: Journal of Community Health / Ausgabe 2/2014
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-013-9773-y

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Under-Reporting of Pelvic Inflammatory Disease in Hawaii: A Comparison of State Surveillance and Hospitalization Data

Pre-test Data and Lessons Learned from a Group Research Project Examining Changes in Physical Activity Behavior Following Construction of a Rails-to-Trails Facility

Colorectal Cancer Screening Among Korean Americans: A Systematic Review

Differences Among College Women for Breast Cancer Prevention Acquired Information-Seeking, Desired Apps and Texts, and Daughter-Initiated Information to Mothers

Cancer Information-Seeking Behaviors and Information Needs Among Korean Americans in the Online Community

Comparing Sugary Drinks in the Food Retail Environment in Six NYC Neighborhoods